Last updated on: 17/05/2021
1. Contact details{View data sources/studies associated with this centre}
Name of organisation 
1) Department/Research groupDepartment of medicine Solna/Clinical epidemiology division
2) Organisation/affiliationKarolinska Institutet
Short Name in the inventoryCentre for Pharmacoepidemiology (CPE)
Administrative Contact
Title Ms
Last name Undén
First name Ulrika
Address line 1Karolinska University Hospital Solna
Address line 2Centre for Pharmacoepidemiology, T2 
Address line 3 
CityStockholm 
Postcode17176 
CountrySweden
Phone number (incl. country code)46851776184 
Alternative phone number 
Fax number (incl. country code)46851779304 
Email address ulrika.unden@ki.se
Scientific Contact
Title Professor
Last name Kieler
First name Helle
Address line 1Karolinska University Hospital Solna
Address line 2Centre for Pharmacoepidemiology, T2 
Address line 3 
CityStockholm 
Postcode171 76 
CountrySweden
Phone number (incl. country code)46851770629 
Alternative phone number46736334492 
Fax number (incl. country code)46851779304 
Email address helle.kieler@ki.se
Alternative Scientific Contact
Title Dr 
Last name Reutfors 
First name Johan 
Address line 1Karolinska University Hospital Solna 
Address line 2Centre for Pharmacoepidemiology, T2 
Address line 3 
CityStockholm 
Postcode171 76 
CountrySweden 
Phone number (incl. country code) 
Alternative phone number 
Fax number (incl. country code) 
Email address johan.reutfors@ki.se 
2. Description
CPE is lead by professor Helle Kieler. Professor Nancy Pedersen is chairman of the steering group which includes representatives from academia, government agencies, regulatory authorities, pharmaceutical industry and Stockholm's county council. CPE strives to meet the demands from both national and international stakeholders in society and industry concerning data on drug safety, drug utilization, rational drug use and pharmacogenetics. Sweden has a unique opportunity to meet these demands by using national healthcare databases, bio banks, as well as having high levels of expertise in the fields of epidemiologically, pharmacology and other areas. CPE is mainly focusing on drug safety evaluation using data from the Swedish national registers. We have identified five research areas where we in particular can provide expert competence: •Chronic diseases and biologics •CNS and drugs •Drugs during pregnancy and infancy •Cardiovascular diseases and drugs •Cancer and drugs
3. Category
University based
Government based
4. Available resources
 In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist Yes No
Statistician Yes No
Clinician Yes No
Clinical Pharmacologist No Yes
Pharmacist Yes No
IT specialist Yes No
Ethics expertise No Yes
Legal expertise No Yes
Regulatory expertise No Yes
Top